Optimind Pharma Corp (OMND) Stock Price & News

All values in CAD	2025-ж. май	2025-ж. авг.	2025-ж. ноя.	2026-ж. фев.
Revenue	35,70 миң	27,05 миң	34,02 миң	24,51 миң
Cost of goods sold	10,53 миң	11,79 миң	18,74 миң	4,62 миң
Cost of revenue	10,53 миң	11,79 миң	18,74 миң	4,62 миң
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	23,77 миң	21,67 миң	34,69 миң	38,25 миң
Operating expense	23,77 миң	21,67 миң	34,69 миң	38,25 миң
Total operating expenses	34,30 миң	33,46 миң	53,44 миң	42,88 миң
Operating income	1,40 миң	-6,41 миң	-19,41 миң	-18,36 миң
Other non operating income	-1,70 миң	-4,42 миң	-9,21 миң	-9,82 миң
EBT including unusual items	-294,00	-10,84 миң	-28,62 миң	-78,18 миң
EBT excluding unusual items	-294,00	-10,84 миң	-28,62 миң	-28,18 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-294,00	-10,84 миң	-28,62 миң	-78,18 миң
Net profit margin	-0,82%	-40,06%	-84,11%	-318,95%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Ask anything